Page last updated: 2024-09-04

carbapenems and Cystic Fibrosis

carbapenems has been researched along with Cystic Fibrosis in 28 studies

Research

Studies (28)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (14.29)	18.2507
2000's	4 (14.29)	29.6817
2010's	15 (53.57)	24.3611
2020's	5 (17.86)	2.80

Authors

Authors	Studies
Baird, T; Bell, SC; Fraser, TA; Madden, DE; Neill, J; Olagoke, O; Price, EP; Ramsay, KA; Sarovich, DS	1
Dargahi, Z; Etemad, A; Ghasemian, E; Hashemian, M; Kaviar, VH; Lohrasbi, A; Saadh, MJ	1
Davis, JJ; Hernandez, RE; Hoffman, LR; Long, SW; Roch, M; Rosato, AE; Rosato, RR; Rose, WE; Saavedra, MO; Taglialegna, A; Varela, MC	1
Almeida, MM; Carvalho-Assef, APD; Firmida, MC; Folescu, TW; Freitas, MT; Leão, RS; Marques, EA	1
Ballard, E; Beatson, SA; Bell, SC; Dave, KA; Duplancic, C; Grimwood, K; Kidd, TJ; Ramsay, KA; Sherrard, LJ; Sidjabat, HE; Wainwright, CE; Wee, BA; Whiley, DM	1
Aitken, E; Gould, IM; Hijazi, K; Joshi, C; Oggioni, MR; Zamudio, R	1
Kemper, AL; Young, DC; Zobell, JT	1
Barth, AL; Hermes, DM; Lutz, L; Martins, AF; Netto, B; Pormann Pitt, C; Ribeiro, VB; Teixeira, AB; Zavascki, AP	1
Arpi, M; Fuursted, K; Hammerum, AM; Hansen, DS; Hansen, F; Heltberg, O; Holm, A; Johansen, HK; Justesen, US; Littauer, P; Lykke, MA; Schumacher, H; Tønning, B; Østergaard, C	1
Bell, SC; Buckley, C; Kidd, TJ; Ramsay, KA; Tai, AS; Whiley, DM	1
Broutin, I; Fournier, D; Llanes, C; Monlezun, L; Plésiat, P; Richardot, C	1
Barth, AL; Carvalho-Assef, AP; da Silva, ÉA; de Abreu e Silva, FA; Ferreira, AG; Firmida, Mde C; Folescu, TW; Leão, RS; Marques, EA; Paixão, VA; Santana, MA	1
Boutoille, D; Bretonnière, C; Caillon, J; Guitton, C; Jacqueline, C; Maitte, A; Potel, G	1
Chalhoub, H; Denis, O; Deplano, A; Elborn, JS; Kahl, BC; Mustafa, MH; Rodriguez-Villalobos, H; Traore, H; Tulkens, PM; Tunney, MM; Van Bambeke, F; Vanderbist, F; Vergison, A	1
Elborn, JS; Parkins, MD	1
Di Pilato, V; Fiscarelli, E; Mugnaioli, C; Neri, AS; Pollini, S; Ricciotti, G; Rossolini, GM	1
Bergen, PJ; Bulitta, JB; Forrest, A; Jacob, J; Li, J; Nation, RL; Paterson, DL; Sidjabat, HE; Tsuji, BT	1
Black, PL; Cirillo, I; Kearns, GL; Redman, R; Vaccaro, N	1
Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT	1
Amoureux, L; Bador, J; Blanc, E; Neuwirth, C	1
Chen, Y; Garber, E; Ge, Y; Kaniga, K; Saiman, L; Wikler, MA; Zhao, Q	1
Brown, SD; Traczewski, MM	1
Acquazzino, D; Goering, RV; Hanson, ND; Khalaf, N; Sammut, P; Wolter, DJ	1
Baxter, IA; Lambert, PA	1
Byrne, S; Connor, P; David, TJ; Dodd, M; Doughty, I; Jenney, M; Maddison, J; Webb, AK	1
Ballestero, S; Baquero, F; Escobar, H; Fernández-Rodríguez, A; Pérez-Díaz, JC; Villaverde, R	1
Ciofu, O; Høiby, N; Jensen, T; Johansen, HK; Koch, C; Pressler, T	1
Christenson, JC; Daly, JA; Korgenski, EK	1

Reviews

4 review(s) available for carbapenems and Cystic Fibrosis

Article	Year
The Status of Carbapenem Resistance in Cystic Fibrosis: A Systematic Review and Meta-Analysis. The Yale journal of biology and medicine, 2022, Volume: 95, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Cystic Fibrosis; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2022
Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:9 Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cystic Fibrosis; Doripenem; Humans; Minocycline; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Stenotrophomonas maltophilia; Tigecycline	2010
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems. Pediatric pulmonology, 2012, Volume: 47, Issue:12 Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cystic Fibrosis; Disease Progression; Humans; Pseudomonas Infections	2012
Use of carbapenems and other antibiotics for pulmonary infections in patients with cystic fibrosis. The Pediatric infectious disease journal, 1996, Volume: 15, Issue:8 Topics: Carbapenems; Cystic Fibrosis; Humans; Pseudomonas Infections	1996

Trials

3 trial(s) available for carbapenems and Cystic Fibrosis

Article	Year
Pharmacokinetics of single-dose doripenem in adults with cystic fibrosis. Journal of clinical pharmacology, 2012, Volume: 52, Issue:11 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cystic Fibrosis; Doripenem; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Young Adult	2012
Clinical evaluation of meropenem versus ceftazidime for the treatment of Pseudomonas spp. infections in cystic fibrosis patients. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Adolescent; Adult; Carbapenems; Ceftazidime; Cephalosporins; Child, Preschool; Cystic Fibrosis; Drug Tolerance; Humans; Liver; Meropenem; Microbial Sensitivity Tests; Nausea; Pseudomonas Infections; Spirometry; Sputum; Thienamycins; Transaminases; Treatment Outcome; Vomiting	1995
Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:1 Topics: Adolescent; Adult; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Microbial; Evaluation Studies as Topic; Humans; Imipenem; Infant; Infant, Newborn; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Species Specificity; Thienamycins	1996

Other Studies

21 other study(ies) available for carbapenems and Cystic Fibrosis

Article	Year
Express Yourself: Quantitative Real-Time PCR Assays for Rapid Chromosomal Antimicrobial Resistance Detection in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2022, 05-17, Volume: 66, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Carbapenems; Cystic Fibrosis; Drug Resistance, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Real-Time Polymerase Chain Reaction	2022
Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA. Communications biology, 2020, 10-22, Volume: 3, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Ceftaroline; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Genome, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Staphylococcal Infections	2020
Carbapenem-Resistant Pseudomonas aeruginosa in Chronic Lung Infection: Current Resistance Profile and Hypermutability in Patients with Cystic Fibrosis. Current microbiology, 2021, Volume: 78, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Cystic Fibrosis; Humans; Lung; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2021
Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2022, Volume: 21, Issue:1 Topics: Adolescent; Adult; Australia; Carbapenems; Cystic Fibrosis; Drug Resistance, Bacterial; Female; Humans; Male; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Whole Genome Sequencing; Young Adult	2022
Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients. International journal of antimicrobial agents, 2019, Volume: 53, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin, Tazobactam Drug Combination; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Scotland; Tazobactam; Whole Genome Sequencing	2019
The use of doripenem in pediatric cystic fibrosis patients in case of meropenem shortages. Pediatric pulmonology, 2014, Volume: 49, Issue:3 Topics: Adolescent; Anti-Bacterial Agents; Burkholderia cenocepacia; Burkholderia Infections; Carbapenems; Child; Cystic Fibrosis; Disease Progression; Doripenem; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas stutzeri; Rhodospirillaceae; Thienamycins; Tobramycin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination	2014
Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa. Journal of medical microbiology, 2013, Volume: 62, Issue:Pt 8 Topics: Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; beta-Lactamases; Brazil; Carbapenems; Cystic Fibrosis; Demography; Drug Resistance, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Phenotype; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum	2013
Characterization of carbapenem nonsusceptible Pseudomonas aeruginosa in Denmark: a nationwide, prospective study. Microbial drug resistance (Larchmont, N.Y.), 2014, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cystic Fibrosis; Denmark; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Serotyping	2014
Molecular surveillance for carbapenemase genes in carbapenem-resistant Pseudomonas aeruginosa in Australian patients with cystic fibrosis. Pathology, 2015, Volume: 47, Issue:2 Topics: Adult; Australia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Cystic Fibrosis; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2015
Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD. International journal of antimicrobial agents, 2015, Volume: 45, Issue:5 Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Culture Media; Cystic Fibrosis; Gene Deletion; Genetic Complementation Test; Gluconates; Humans; Mutant Proteins; Porins; Pseudomonas aeruginosa; Pseudomonas Infections	2015
Low-level resistance and clonal diversity of Pseudomonas aeruginosa among chronically colonized cystic fibrosis patients. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2015, Volume: 123, Issue:12 Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Child; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult	2015
MIC score, a new tool to compare bacterial susceptibility to antibiotics application to the comparison of susceptibility to different penems of clinical strains of Pseudomonas aeruginosa. The Journal of antibiotics, 2016, Volume: 69, Issue:11 Topics: Anti-Bacterial Agents; Carbapenems; Cystic Fibrosis; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins	2016
Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; Belgium; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Gene Expression; Germany; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; United Kingdom	2016
Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Chronic Disease; Cystic Fibrosis; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Epidemics; Female; Humans; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections	2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12 Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Colony Count, Microbial; Cystic Fibrosis; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Half-Life; Humans; Models, Biological; Pseudomonas aeruginosa; Pseudomonas Infections	2011
Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1 Topics: Achromobacter denitrificans; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genes, MDR; Genome, Bacterial; Gram-Negative Bacterial Infections; High-Throughput Nucleotide Sequencing; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Respiratory Tract Infections; Sequence Analysis, DNA	2013
In vitro activity of doripenem (S-4661) against multidrug-resistant gram-negative bacilli isolated from patients with cystic fibrosis. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:6 Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Carbapenems; Cystic Fibrosis; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2005
In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:2 Topics: Anti-Bacterial Agents; Burkholderia cepacia; Carbapenems; Cystic Fibrosis; Doripenem; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2006
Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jun-15, Volume: 46, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cystic Fibrosis; DNA Transposable Elements; DNA, Bacterial; Humans; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum	2008
Are all carbapenems created equal? The Journal of antimicrobial chemotherapy, 1995, Volume: 35, Issue:5 Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burkholderia cepacia; Carbapenems; Cystic Fibrosis; Humans; Pseudomonas Infections	1995
In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients. The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:6 Topics: Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins	2000